Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Phase 3 Study of Venetoclax and Azacitidine as Maintenance Therapy for Patients With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy

NCT04102020 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04102020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04102020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Phase 3 Study of Venetoclax and Azacitidine as Maintenance Therapy for Patients With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
Lead sponsor
AbbVie
Phase
Phase 3
Overall status
Completed
Start date
March 26, 2020
Completion date
February 20, 2026
Enrollment
112 (actual)
Sites
156

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia (aml)